Baird Medical Investment HolBDMD
13F holders, Q1 2025 (March 31)6holders
2new positions
2sold out
$4.59avg. 13F price*
At the end of Q1 2025, 6 institutions reported holding Baird Medical Investment Hol (BDMD) in their 13F filings, unchanged from Q4 2024. 2 opened new positions and 2 sold out. The largest holders were Highbridge Capital Management LLC ($651K), Periscope Capital Inc. ($431K) and UBS Group AG ($297K).
- Company
- Baird Medical Investment Hol
- CUSIP
- G0705H103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $180K |
| Exits | 2 | $424K |
All 13F filers, Q4 2024 → Q1 2025: 107,686 shares bought and 55,750 shares sold, net +51,936 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Highbridge Capital Management LLC | 0.10% | Add +11.1% | 125,000 | $651K |
| Periscope Capital Inc. | 0.27% | No change | 125,000 | $431K |
| UBS Group AG | 0.00% | Add +3949.6% | 56,937 | $297K |
| XTX Topco Ltd | 0.01% | New | 21,395 | $111K |
| Geode Capital Management, LLC | 0.00% | Add +47.0% | 15,931 | $83K |
| Morgan Stanley | 0.00% | New | 13,167 | $69K |
"% of holder's portfolio" is BDMD's weight in each manager's 13F, not the share of Baird Medical Investment Hol the manager owns.